<code id='A089890BD8'></code><style id='A089890BD8'></style>
    • <acronym id='A089890BD8'></acronym>
      <center id='A089890BD8'><center id='A089890BD8'><tfoot id='A089890BD8'></tfoot></center><abbr id='A089890BD8'><dir id='A089890BD8'><tfoot id='A089890BD8'></tfoot><noframes id='A089890BD8'>

    • <optgroup id='A089890BD8'><strike id='A089890BD8'><sup id='A089890BD8'></sup></strike><code id='A089890BD8'></code></optgroup>
        1. <b id='A089890BD8'><label id='A089890BD8'><select id='A089890BD8'><dt id='A089890BD8'><span id='A089890BD8'></span></dt></select></label></b><u id='A089890BD8'></u>
          <i id='A089890BD8'><strike id='A089890BD8'><tt id='A089890BD8'><pre id='A089890BD8'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:585
          A close up photograph of an IV drop in a Portland hospital – politics and policy coverage from STAT
          A patient receives an IV drip at a hospital in Portland, Ore. Jenny Kane/AP

          WASHINGTON — A new White House task force on drug shortages held a rare in-person meeting last Friday with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm policies for stemming shortages of cancer drugs.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          AstraZeneca stays mum on Medicare drug pricing negotiations
          AstraZeneca stays mum on Medicare drug pricing negotiations

          AstraZenecaCEOPascalSoriotJacquelynMartin/APLONDON—Medicare’sfirst-everdrugpricingnegotiationsareoff

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Why Novartis is going to walk from its acquisition of MorphoSys

          MollyFerguson/STATNovartissaidMondaythatitintendstobuyMorphoSysforjustunder$3billion.Thedealwillnotc